E-viri
Recenzirano
-
Mendelson, Marc, Prof; Røttingen, John-Arne, Prof; Gopinathan, Unni, MD; Hamer, Davidson H, Prof; Wertheim, Heiman, MD; Basnyat, Buddha, MD; Butler, Christopher, Prof; Tomson, Göran, Prof; Balasegaram, Manica, MD
The Lancet (British edition), 01/2016, Letnik: 387, Številka: 10014Journal Article
Summary Access to quality-assured antimicrobials is regarded as part of the human right to health, yet universal access is often undermined in low-income and middle-income countries. Lack of access to the instruments necessary to make the correct diagnosis and prescribe antimicrobials appropriately, in addition to weak health systems, heightens the challenge faced by prescribers. Evidence-based interventions in community and health-care settings can increase access to appropriately prescribed antimicrobials. The key global enablers of sustainable financing, governance, and leadership will be necessary to achieve access while preventing excess antimicrobial use.
